# Antiviral Drugs Advisory Committee; Amendment of Notice
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Notice.
The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Antiviral Drugs Advisory Committee. This meeting was announced in the *Federal Register* of February 2, 2007 (72 FR 5724). The amendment is being made to reflect a change in the *Location* portion of the document. There are no other changes.
**FOR FURTHER INFORMATION CONTACT:**
Cicely Reese, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093) Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, e-mail: *[email protected]* , or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington DC area), code 3014512531. Please call the Information Line for up-to-date information on this meeting.
**SUPPLEMENTARY INFORMATION:**
In the *Federal Register* of February 7, 2007, FDA announced that a meeting of the Antiviral Drugs Advisory Committee would be held on April 24, 2007. On page 5724, in the first column, the *Location* portion of document is amended to read as follows:
*Location* : Crowne Plaza Hotel, Kennedy Ballrooms, 8777 Georgia Ave., Silver Spring, MD. The hotel telephone number is 800-971-4654.
This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.
Dated: April 18, 2007.
Randall W. Lutter,
Associate Commissioner for Policy and Planning.